Cost-effectiveness of interventions for anxiety and depressive disorders

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Otherpeer-review

2 Citations (Scopus)

Abstract

Depression and anxiety disorders are highly prevalent diagnoses associated with significant morbidity and economic burden to healthcare systems and society. It is important to consider the costs and outcomes of the various pharmacologic and psychologic therapies available for the treatment and prevention of these diagnoses in order to provide services in the most efficient way. This chapter reviews the numerous economic evaluations previously undertaken to evaluate medications and the psychological (both in-person and Internet-based) and combination therapies used as treatments for diagnosed depression and anxiety. It also reviews the growing literature on interventions for the prevention of these conditions. A discussion of methodologic concerns is included to provide guidance for interpreting the existing evidence and as a basis for the design of future evaluations.

Original languageEnglish
Title of host publicationMental Health Economics
Subtitle of host publicationThe Costs and Benefits of Psychiatric Care
EditorsDenise Razzouk
Place of PublicationSwitzerland
PublisherSpringer
Chapter18
Pages283-298
Number of pages16
ISBN (Electronic)9783319552668
ISBN (Print)9783319552651
DOIs
Publication statusPublished - 26 Aug 2017
Externally publishedYes

Cite this